Structural Heart Device is used for Structural heart disease which is a problem with the tissues or valves of the heart. Many, structural heart diseases are congenital, which means present at birth. Some structural heart disease will develop later in life. Others disease like stroke can also be treated using left atrial appendage occluders which also has been included as structural heart device in this report
This report contains market size and forecasts of Transcatheter Structural Heart Device in global, including the following market information:
Global Transcatheter Structural Heart Device Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Transcatheter Structural Heart Device Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Transcatheter Structural Heart Device companies in 2021 (%)
The global Transcatheter Structural Heart Device market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Left Atrial Appendage Occluders Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Transcatheter Structural Heart Device include Medtronic, Boston Scientific Corporation, Abbott, Edwards Lifesciences Corporation, Lifetech, Braile Biomedica, Micro Interventional Devices, LivaNova PLC and Cryolife, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Transcatheter Structural Heart Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Transcatheter Structural Heart Device Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Transcatheter Structural Heart Device Market Segment Percentages, by Type, 2021 (%)
Left Atrial Appendage Occluders
Septal Defect Occluders
Aortic Valve Replacement
Mitral Valve Repair
Mitral Valve Replacement (Experimental)
Global Transcatheter Structural Heart Device Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Transcatheter Structural Heart Device Market Segment Percentages, by Application, 2021 (%)
Congenital Heart Defects
Aortic Stenosis
Mitral Regurgitation
Stroke
Others
Global Transcatheter Structural Heart Device Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Transcatheter Structural Heart Device Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Transcatheter Structural Heart Device revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Transcatheter Structural Heart Device revenues share in global market, 2021 (%)
Key companies Transcatheter Structural Heart Device sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Transcatheter Structural Heart Device sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
Boston Scientific Corporation
Abbott
Edwards Lifesciences Corporation
Lifetech
Braile Biomedica
Micro Interventional Devices
LivaNova PLC
Cryolife
Neovasc
4C Medical Technologies
Highlife
Lepu Medical
Dinova Medtech
NewMed Medical
Venus Medtech
Hanyu Medical